1. Home
  2. MFIN vs TNXP Comparison

MFIN vs TNXP Comparison

Compare MFIN & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medallion Financial Corp.

MFIN

Medallion Financial Corp.

HOLD

Current Price

$11.95

Market Cap

276.7M

Sector

Finance

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$10.77

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFIN
TNXP
Founded
1995
2007
Country
United States
United States
Employees
179
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
276.7M
199.7M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
MFIN
TNXP
Price
$11.95
$10.77
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
51.9K
408.5K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
5.18%
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
N/A
$558.11
Revenue Next Year
$0.02
$38.29
P/E Ratio
$6.21
N/A
Revenue Growth
N/A
29.85
52 Week Low
$7.85
$9.40
52 Week High
$12.26
$27.27

Technical Indicators

Market Signals
Indicator
MFIN
TNXP
Relative Strength Index (RSI) 60.14 30.73
Support Level $11.40 $10.03
Resistance Level $12.26 $13.18
Average True Range (ATR) 0.26 0.58
MACD -0.07 -0.30
Stochastic Oscillator 71.10 6.11

Price Performance

Historical Comparison
MFIN
TNXP

About MFIN Medallion Financial Corp.

Medallion Financial Corp is a finance company that originates and services loans in various industries. The four operating segments are, (1) recreation, (2) home improvement, (3) commercial and (4) taxi medallion The company generates maximum revenue from the Recreation segment. The company's geographic Concentrations are in united states diversified in California, Wisconsin, New York, Texas and others.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: